With more than 60 percent of cancers in the United States occurring in people age 65 and older, the evidence base for treating older adults is sparse.
ASCO recently presented a position statement “Improving the Evidence Base for Treating Older Adults with Cancer.” With more than 60 percent of cancers in the United States occurring in people age 65 and older, the evidence base for treating older adults is sparse because they are underrepresented in clinical trials and trials designed specifically for them are rare. Developed by ASCO’s Cancer Research Committee, the organization call for five over-arching recommendations:
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.